Exploration of attractor modules for sporadic amyotrophic lateral sclerosis via systemic module inference and attract method

Zhang,Fang; Liu,Mei; Li,Qun; Song,Fei-Xue

doi:10.3892/etm.2019.7264

Exploration of attractor modules for sporadic amyotrophic lateral sclerosis via systemic module inference and attract method

Authors:
- Fang Zhang
- Mei Liu
- Qun Li
- Fei-Xue Song
View Affiliations

Affiliations: Department of Rehabilitation, The Second Hospital of Lanzhou University, Lanzhou, Gansu 730030, P.R. China, Department of Oncology, The Second Hospital of Lanzhou University, Lanzhou, Gansu 730030, P.R. China
Published online on: February 13, 2019 https://doi.org/10.3892/etm.2019.7264
Pages: 2575-2580
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Sporadic amyotrophic lateral sclerosis (SALS) is a devastating neurodegenerative disorder. However, the understanding of SALS is still poor. This research aimed to excavate attractor modules for SALS by integrating the systemic module inference and attract method. To achieve this, gene expression data and protein-protein data were recruited and preprocessed. Then, based on the Spearman's correlation coefficient (SCC) of the interactions under these two conditions, two PPI networks separately with 870 nodes (979 interactions) in normal control group and 601 nodes (777 interactions) in SALS group were built. Systemic module inference method was performed to identify the modules, and attract method was used to identify attractor modules. Finally, pathway enrichment analysis was performed to disclose the functional enrichment of these attractor modules. In total 44 and 118 modules were identified for normal control and SALS groups, respectively. Among them, 6 modules were with similar gene composition between the two groups, and all 6 modules were considered as the attractor module via attract method. These attractor modules might be potential biomarkers for early diagnosis and therapy of SALS, which could provide insight into the disease biology and suggest possible directions for drug screening programs.

View Figures

View References

1	Carvalho TL, de Almeida LM, Lorega CM, Barata MF, Ferreira ML, de Brito-Marques PR and Correia Cda C: Depression and anxiety in individuals with amyotrophic lateral sclerosis: A systematic review. Trends Psychiatry Psychother. 38:1–5. 2016. View Article : Google Scholar : PubMed/NCBI
2	Leblond CS, Gan-Or Z, Spiegelman D, Laurent SB, Szuto A, Hodgkinson A, Dionne-Laporte A, Provencher P, de Carvalho M, Orrù S, et al: Replication study of MATR3 in familial and sporadic amyotrophic lateral sclerosis. Neurobiol Aging. 37:209.e17–209.e21. 2016. View Article : Google Scholar
3	Basu S, Baghel NS, Puri A, Shet T and Merchant NH: 18 F-FDG avid lesion due to coexistent fibrous dysplasia in a child of embryonal rhabdomyosarcoma: Source of false positive FDG-PET. J Cancer Res Ther. 6:92–94. 2010. View Article : Google Scholar : PubMed/NCBI
4	Renton AE, Chiò A and Traynor BJ: State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 17:17–23. 2014. View Article : Google Scholar : PubMed/NCBI
5	Poppe L, Rué L, Robberecht W and Van Den Bosch L: Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS). Exp Neurol. 262:138–151. 2014. View Article : Google Scholar : PubMed/NCBI
6	Ahmed RM, Irish M, Piguet O, Halliday GM, Ittner LM, Farooqi S, Hodges JR and Kiernan MC: Amyotrophic lateral sclerosis and frontotemporal dementia: Distinct and overlapping changes in eating behaviour and metabolism. Lancet Neurol. 15:332–342. 2016. View Article : Google Scholar : PubMed/NCBI
7	Tiloca C, Ticozzi N, Pensato V, Corrado L, Del Bo R, Bertolin C, Fenoglio C, Gagliardi S, Calini D, Lauria G, et al: SLAGEN Consortium: Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia. Neurobiol Aging. 34:1517.e9–1517.e10. 2013. View Article : Google Scholar
8	Fogh I, Lin K, Tiloca C, Rooney J, Gellera C, Diekstra FP, Ratti A, Shatunov A, van Es MA, Proitsi P, et al: Association of a locus in the CAMTA1 gene with survival in patients with sporadic amyotrophic lateral sclerosis. JAMA Neurol. 73:812–820. 2016. View Article : Google Scholar : PubMed/NCBI
9	Lin KP, Tsai PC, Liao YC, Chen WT, Tsai CP, Soong BW and Lee YC: Mutational analysis of MATR3 in Taiwanese patients with amyotrophic lateral sclerosis. Neurobiol Aging. 36:2005.e1–4. 2015. View Article : Google Scholar
10	Aronica E, Baas F, Iyer A, ten Asbroek AL, Morello G and Cavallaro S: Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortex. Neurobiol Dis. 74:359–376. 2015. View Article : Google Scholar : PubMed/NCBI
11	Jordán F, Nguyen T-P and Liu WC: Studying protein-protein interaction networks: A systems view on diseases. Brief Funct Genomics. 11:497–504. 2012. View Article : Google Scholar : PubMed/NCBI
12	Choi JK, Yu U, Yoo OJ and Kim S: Differential coexpression analysis using microarray data and its application to human cancer. Bioinformatics. 21:4348–4355. 2005. View Article : Google Scholar : PubMed/NCBI
13	Ravasz E, Somera AL, Mongru DA, Oltvai ZN and Barabási AL: Hierarchical organization of modularity in metabolic networks. Science. 297:1551–1555. 2002. View Article : Google Scholar : PubMed/NCBI
14	Srihari S and Ragan MA: Systematic tracking of dysregulated modules identifies novel genes in cancer. Bioinformatics. 29:1553–1561. 2013. View Article : Google Scholar : PubMed/NCBI
15	Mar JC, Matigian NA, Quackenbush J and Wells CA: attract: A method for identifying core pathways that define cellular phenotypes. PLoS One. 6:e254452011. View Article : Google Scholar : PubMed/NCBI
16	Ma L, Robinson LN and Towle HC: ChREBP*Mlx is the principal mediator of glucose-induced gene expression in the liver. J Biol Chem. 281:28721–28730. 2006. View Article : Google Scholar : PubMed/NCBI
17	Rifai N and Ridker PM: Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening. Clin Chem. 47:28–30. 2001.PubMed/NCBI
18	Pepper SD, Saunders EK, Edwards LE, Wilson CL and Miller CJ: The utility of MAS5 expression summary and detection call algorithms. BMC Bioinformatics. 8:2732007. View Article : Google Scholar : PubMed/NCBI
19	Giorgi FM, Bolger AM, Lohse M and Usadel B: Algorithm-driven artifacts in median polish summarization of microarray data. BMC Bioinformatics. 11:5532010. View Article : Google Scholar : PubMed/NCBI
20	Liu G, Wong L and Chua HN: Complex discovery from weighted PPI networks. Bioinformatics. 25:1891–1897. 2009. View Article : Google Scholar : PubMed/NCBI
21	Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL and Massagué J: Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 451:147–152. 2008. View Article : Google Scholar : PubMed/NCBI
22	Tomita E, Tanaka A and Takahashi H: The worst-case time complexity for generating all maximal cliques and computational experiments. Theor Comput Sci. 363:28–42. 2006. View Article : Google Scholar
23	Mohseni-Zadeh S, Brézellec P and Risler J-L: Cluster-C: an algorithm for the large-scale clustering of protein sequences based on the extraction of maximal cliques. Comput Biol Chem. 28:211–208. 2004. View Article : Google Scholar : PubMed/NCBI
24	Srihari S and Leong HW: A survey of computational methods for protein complex prediction from protein interaction networks. J Bioinform Comput Biol. 11:12300022013. View Article : Google Scholar : PubMed/NCBI
25	Seifoddini H and Djassemi M: The production data-based similarity coefficient versus Jaccard's similarity coefficient. Comput Ind Eng. 21:263–266. 1991. View Article : Google Scholar
26	Tian L, Greenberg SA, Kong SW, Altschuler J, Kohane IS and Park PJ: Discovering statistically significant pathways in expression profiling studies. Proc Natl Acad Sci USA. 102:13544–13549. 2005. View Article : Google Scholar : PubMed/NCBI
27	Benjamini Y and Hochberg Y: Controlling The false discovery rate - A practical and powerful approach to multiple testing. J R Stat Soc Ser A Stat Soc. 57:289–300. 1995.
28	Yokoi D, Atsuta N, Watanabe H, Nakamura R, Hirakawa A, Ito M, Watanabe H, Katsuno M, Izumi Y, Morita M, et al: JaCALS: Age of onset differentially influences the progression of regional dysfunction in sporadic amyotrophic lateral sclerosis. J Neurol. 263:1129–1136. 2016. View Article : Google Scholar : PubMed/NCBI
29	Allen SP, Rajan S, Duffy L, Mortiboys H, Higginbottom A, Grierson AJ and Shaw PJ: Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis. Neurobiol Aging. 35:1499–1509. 2014. View Article : Google Scholar : PubMed/NCBI
30	Calingasan NY, Chen J, Kiaei M and Beal MF: Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients. Neurobiol Dis. 19:340–347. 2005. View Article : Google Scholar : PubMed/NCBI
31	Bogdanov M, Brown RH Jr, Matson W, Smart R, Hayden D, O'Donnell H, Flint Beal M and Cudkowicz M: Increased oxidative damage to DNA in ALS patients. Free Radic Biol Med. 29:652–658. 2000. View Article : Google Scholar : PubMed/NCBI
32	D'Amico E, Factor-Litvak P, Santella RM and Mitsumoto H: Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis. Free Radic Biol Med. 65:509–527. 2013. View Article : Google Scholar : PubMed/NCBI
33	Abalkhail H, Mitchell J, Habgood J, Orrell R and de Belleroche J: A new familial amyotrophic lateral sclerosis locus on chromosome 16q12.1-16q12.2. Am J Hum Genet. 73:383–389. 2003. View Article : Google Scholar : PubMed/NCBI
34	Miyata A, Arimura A, Dahl RR, Minamino N, Uehara A, Jiang L, Culler MD and Coy DH: Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun. 164:567–574. 1989. View Article : Google Scholar : PubMed/NCBI
35	Dickson L and Finlayson K: VPAC and PAC receptors: From ligands to function. Pharmacol Ther. 121:294–316. 2009. View Article : Google Scholar : PubMed/NCBI
36	Ringer C, Büning LS, Schäfer MKH, Eiden LE, Weihe E and Schütz B: PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Neurobiol Dis. 54:32–42. 2013. View Article : Google Scholar : PubMed/NCBI